Approvals for drugs from Biogen Inc. and Sarepta Therapeutics Inc. show flaws in the process US drug regulators use to speed ...

Outlook Therapeutics, Inc. (NASDAQ:OTLK) completed the analysis of the complete 12-week safety and efficacy results for NORSE ...

MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) has been granted a U.S. patent for the use of its leading compound, buntanetap, ...

The opening of the country's first legal drug consumption facility is a "potentially transformative moment in UK drugs policy ...

One of Scotland’s leading residential rehab centres for people with drug and alcohol addictions has become the first in the ...

Supermarket shoppers’ eyes aren’t playing tricks on them. Gerrity’s has implemented new blue lighting in its bathrooms to ...

U.S. drugmaker Pfizer is going "all in" to develop its experimental obesity drug and has been recruiting more experts in that ...

The UK government on Wednesday banned the flesh-rotting so-called zombie drug xylazine as it tries to tackle deaths from narcotics and crack down on criminal gangs.

AbbVie will commit less capital towards experimental medicines for psychiatric disease, CEO Robert Michael said at an ...

It is hoped The Thistle - based in Glasgow's east end - will help addicts access wider support to improve their lives, as ...

Fortress Biotech, Inc. (NASDAQ:FBIO), a biopharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has extended the target action date for the New Drug Application ...

Intra-Cellular has had success selling Caplyta, a brain-rebalancing drug that's approved to treat schizophrenia and bipolar ...